Literature DB >> 12085556

[Physical diagnosis--Ortolani's manoeuvre].

R M Castelein1.   

Abstract

Ortolani's manoeuvre is used to detect hip instability. It is intended to be used to establish the mobility of a dislocated femoral head with respect to the acetabulum in newly-born infants. Barlow's modification attempts to dislocate a reduced but unstable hip out of the acetabulum. Ortolani's manoeuvre is a primarily tactile, proprioceptive sensation and has nothing to do with the usually inconsequential audible and palpable clicks in infant hips. It has been found that widespread use of Ortolani's manoeuvre cannot prevent all late diagnoses of hip dysplasia. This is because neonatal hip instability is only part of the total spectrum of hip dysplasia, and because the examination requires a relaxed newly-born infant and an experienced examiner. In the Dutch situation, general screening with Ortolani's manoeuvre is not advisable as this will lead to many false-positive and false-negative outcomes due to this neonatal examination being carried out by various physicians and midwives with insufficient experience. Better results may be expected from ultrasound screening at child welfare clinics. This is presently being investigated in a large population study.

Entities:  

Mesh:

Year:  2002        PMID: 12085556

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  2 in total

1.  Effectiveness of ultrasound screening for developmental dysplasia of the hip.

Authors:  E A Roovers; M M Boere-Boonekamp; R M Castelein; G A Zielhuis; T H Kerkhoff
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

2.  Developmental dysplasia of the hip in children with Down syndrome: comparison of clinical and radiological examinations in a local cohort.

Authors:  Anouk F M van Gijzen; Elsbeth D M Rouers; Florens Q M P van Douveren; Jeanne Dieleman; Johannes G E Hendriks; Feico J J Halbertsma; Levinus A Bok
Journal:  Eur J Pediatr       Date:  2019-02-01       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.